Thomson Reuters announced this morning that it has entered into an agreement to sell its healthcare unit to Veritas Capital for $1.25 billion in cash. The company offers analytics services, clinical decision support, an HIE solution, and the Micromedex drug information reference.
Robert McKeon, chairman of Veritas Capital, was quoted as saying, “The Healthcare business of Thomson Reuters is the preeminent healthcare analytics company in the industry today. The acquisition will provide us with a unique and exciting opportunity to add a truly outstanding business and world-class management team to our portfolio and we look forward to building upon our experience in the healthcare analytics market. We look forward to welcoming the business and its talented employees, including its talented management team led by Mike Boswood, into the Veritas family.”